These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 34661893)

  • 21. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
    Ietto G
    Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
    El Baba R; Herbein G
    Clin Epigenetics; 2020 Aug; 12(1):118. PubMed ID: 32758273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
    Varghese PM; Tsolaki AG; Yasmin H; Shastri A; Ferluga J; Vatish M; Madan T; Kishore U
    Immunobiology; 2020 Nov; 225(6):152008. PubMed ID: 33130519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status in cellular-based therapies for prevention and treatment of COVID-19.
    Hattab D; Amer MFA; Mohd Gazzali A; Chuah LH; Bakhtiar A
    Crit Rev Clin Lab Sci; 2023 Aug; 60(5):321-345. PubMed ID: 36825325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
    Ruenjaiman V; Hirankarn N; Palaga T
    Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunologic response to severe acute respiratory syndrome coronavirus 2.
    Le NK; Kaman K; Martin HC; Mullur J; Stenehjem KK; Coomar L; Bahar B; Dutta M; Izurieta R; Brooks JP
    Allergy Asthma Proc; 2021 Nov; 42(6):495-505. PubMed ID: 34871157
    [No Abstract]   [Full Text] [Related]  

  • 27. What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders.
    Maggi E; Azzarone BG; Canonica GW; Moretta L
    Allergy; 2022 Apr; 77(4):1114-1128. PubMed ID: 34582050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes.
    Dastar S; Gharesouran J; Mortazavi D; Hosseinzadeh H; Kian SJ; Taheri M; Ghafouri-Fard S; Jamali E; Rezazadeh M
    Hum Antibodies; 2022; 30(1):1-14. PubMed ID: 34864654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Epithelial-Endothelial Cell Interaction in the Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Hui KP; Cheung MC; Lai KL; Ng KC; Ho JC; Peiris M; Nicholls JM; Chan MC
    Clin Infect Dis; 2022 Jan; 74(2):199-209. PubMed ID: 33956935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19: Inflammatory Profile.
    Wang Y; Perlman S
    Annu Rev Med; 2022 Jan; 73():65-80. PubMed ID: 34437814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of SARS-CoV-2 and
    Shah T; Shah Z; Yasmeen N; Baloch Z; Xia X
    Front Immunol; 2022; 13():909011. PubMed ID: 35784278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses.
    Yi J; Miao J; Zuo Q; Owusu F; Dong Q; Lin P; Wang Q; Gao R; Kong X; Yang L
    Front Immunol; 2022; 13():978619. PubMed ID: 36091053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
    Mok DZL; Chan CYY; Ooi EE; Chan KR
    FEBS J; 2021 Sep; 288(17):5055-5070. PubMed ID: 33124149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic.
    Li X; Zhang Y; He L; Si J; Qiu S; He Y; Wei J; Wang Z; Xie L; Li Y; Teng T
    Int J Biol Sci; 2022; 18(5):1865-1877. PubMed ID: 35342348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Game of Infection - Song of Respiratory Viruses and Interferons.
    Wang GQ; Gu Y; Wang C; Wang F; Hsu AC
    Front Cell Infect Microbiol; 2022; 12():937460. PubMed ID: 35846766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 associated pathogenesis, immune dysfunction and involvement of host factors: a comprehensive review.
    Waqar W; Ismail S; Jamil Z; Al-Shehhi A; Imran M; Hetta HF; Muhammad K; Waheed Y
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7526-7542. PubMed ID: 34919255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immune system view of the coronavirus SARS-CoV-2.
    Celardo I; Pace L; Cifaldi L; Gaudio C; Barnaba V
    Biol Direct; 2020 Dec; 15(1):30. PubMed ID: 33371901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
    Chen P; Wu M; He Y; Jiang B; He ML
    Signal Transduct Target Ther; 2023 Jun; 8(1):237. PubMed ID: 37286535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.